The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms

References

• Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol.101, 1900–1920 (2006).
   PubMed Web of Science ®Google Scholar
• Jasperson D, Kulig M, Labenz J et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD study. Aliment. Pharmacol. Ther.217, 1515–1520 (2003).
   Google Scholar
• Dent J, El-Serag HB, Wallander MA et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut54, 710–717 (2005).
   PubMed Web of Science ®Google Scholar
• Jayadevappa R, Chhatre S, Weiner M. Gastro-oesophageal acid-related disease, co-morbidity and medical care cost. Chronic Illness4, 209–218 (2004).
   Google Scholar
• Shaheen NJ, Hansen RA, Morgan DR et al. The burden of gastrointestinal and liver diseases. Am. J. Gastroenterol.101, 2128–2138 (2006).
   PubMed Web of Science ®Google Scholar
• Joish VN, Donaldson G, Stockdale W et al. The economic impact of GERD and PUD: examination of direct and indirect costs. Curr. Med. Res. Opin.21, 535–543 (2005).
   PubMed Web of Science ®Google Scholar
• Brook RA, Wahlqvist P, Kleinman NL et al. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Aliment. Pharmacol. Ther.26, 889–898 (2007).
   PubMed Web of Science ®Google Scholar
• Wahlqvist P, Reilly MC, Barkun A. Systematic review: the impact of gastro- oesophageal reflux disease on work productivity. Aliment. Pharmacol. Ther.24, 259–272 (2006).
   PubMed Web of Science ®Google Scholar
• Dean BB, Crawley JA, Schmitt CM et al. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment. Pharmacol. Ther.17, 1309–1317 (2003).
   PubMed Web of Science ®Google Scholar
• Toghanian S, Wahlqvist P, Johnson,DA, Bolge SC, Liljas B. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts. Clin. Drug Invest.30, 167–178 (2010).
   PubMed Web of Science ®Google Scholar
• King A, MacDonald C, Orn C. Understanding gastro-oesophageal reflux disease: a patient-cluster analysis. Int. J. Clin. Pract.62, 1838–1843 (2008).
   PubMed Web of Science ®Google Scholar
• Wahlqvist P, Karlsson M, Johnson D et al. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment. Pharmacol. Ther.27, 960–970 (2008).
   PubMed Web of Science ®Google Scholar
• Mody R, Bolge SC, Kannan H et al. Effects of gastroesophageal reflux disease on sleep and outcomes. Clin. Gastroenterol. Hepatol.7, 953–959 (2009).
   PubMed Web of Science ®Google Scholar
• Fass R. Effect of gastroesophageal refluxdisease on sleep. J. Gastroenterol. Hepatol.25, S41–S44 (2010).
   PubMedGoogle Scholar
• Nocon M, Labenz J, Jaspersen D et al. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment. Pharmacol. Ther.29, 662–668 (2009).
   PubMed Web of Science ®Google Scholar
• Daley M, Morin CM, LeBlanc M et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep32, 55–64 (2009).
   PubMed Web of Science ®Google Scholar
• Stoller MK. Economic effects of insomnia. Clin. Ther.16, 873–897 (1994).
   PubMed Web of Science ®Google Scholar
• Ozminkowski RJ, Shaohung SW, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep30, 263–273 (2007).
   PubMed Web of Science ®Google Scholar
• Dubois RW, Aguilar D, Fass R et al. Consequences of frequent nocturnal GERD among employed adults: symptom severity, quality of life and work productivity. Aliment. Pharmacol. Ther.25, 487–500 (2007).
   PubMed Web of Science ®Google Scholar
• Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch. Intern. Med.167, 540–549 (2007).
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Fitzgerald S, Richardson P. The extent and determinants of prescribing and adherence with acid-reducing medication: a national claims database study. Am. J. Gastroenterol.104, 2161–2167 (2009).
   PubMed Web of Science ®Google Scholar
• DiBonaventura MD, Wagner JS, Yuan Y et al. Humanistic and economic impacts of hepatitis C in the United States. J. Med. Econ.13, 709–718 (2010).
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis.40, 373–383 (1987).
   PubMedGoogle Scholar
• Ware Jr J, Kosinski M, Turner-Bowker DM et al. How to Score Version 2 of the SF-12v2 Health Survey (With a Supplement Documenting Version 1). QualityMetric Inc., RI, USA (2002).
   Google Scholar
• Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM. The cost diary: a method to measure direct and indirect costs in cost–effectiveness research. J. Clin. Epidemiol.53, 688–695 (2000).
   PubMed Web of Science ®Google Scholar
• Petrou S, Murray L, Cooper P, Davidson LL. The accuracy of self-reported healthcare resource utilization in health economic studies. Int. J. Technol. Assess. Health Care18, 705–710 (2002).
   PubMed Web of Science ®Google Scholar
• Pinto D, Robertson MC, Hansen P, Abbott JH. Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis. BMC Med. Res. Methodol.11, 45 (2011).
   PubMedGoogle Scholar
• Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Serv. Res.37, 751–774 (2002).
   PubMed Web of Science ®Google Scholar
• Ritter PL, Stewart AL, Kaymaz H et al. Self-reports of health care utilization compared to provider records. J. Clin. Epidemiol.54, 136–141 (2001).
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics4, 353–365 (1993).
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measurement of medication adherence and long-term predictive validity of blood pressure control. Med. Care24, 67–74 (1986).
   PubMed Web of Science ®Google Scholar
• Machlin SR. Expenses for a Hospital Emergency Room Visit, 2003. (Statistical Brief 111, January 2006). Medical Expenditure Panel Survey, MD, USA (2006).
   Google Scholar
• Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann. Med.33, 350–357 (2001).
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Cooper A, Karagiannis D et al. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual. Life Outcomes7, 90–96 (2009).
   PubMedGoogle Scholar
• Wahlqvist P, Brook RA, Campbell SM et al. Objective measurement of work absence and on-the-job productivity: a case–control study of US employees with and without gastroesophageal reflux disease. J. Occup. Environ. Med.50, 25–31 (2008).
   PubMed Web of Science ®Google Scholar
• Rey E, Moreno-Elola-Elaso C, Rodriguez-Artalejo F, Diaz-Rubio M. Medical consultation for gastro-oesophageal reflux symptoms: reasons and associated factors. Digestion70, 173–177 (2004).
   PubMed Web of Science ®Google Scholar